Oct 26, 2026
Two Papers From Variant Bio Led Study Describe Founder Effects and Genetic Variants in Polynesia
Stephane Castel, Variant Bio Founder, Chief Technology Officer & Chief Scientific Officer
Exceptional traits among us
Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits.
Human genetics, multi-omics, and AI have the power to transform drug development
Drug development has become increasingly difficult due to high costs and failure rates. Insights from human genetics, multi-omics, and AI can identify the molecular basis of disease and more than double the success rate of clinical trials.
A cross-disciplinary team committed to making a difference
Our team has expertise spanning genetics, drug discovery and development, molecular biology, anthropology, and ethics. We started Variant Bio because we share the belief that human genomics research has the power to transform drug development.
At Variant Bio, ethics is a priority, not an afterthought
We are committed to working in a way that respects the privacy, beliefs, cultures, and data of the populations we partner with. We recognize the contribution of partner communities through unique benefit-sharing programs.
Recent Highlights
